These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2889346

  • 21. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P.
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [Abstract] [Full Text] [Related]

  • 22. alpha 1-antagonists in the treatment of hypertension.
    Grimm RH.
    Hypertension; 1989 May; 13(5 Suppl):I131-6. PubMed ID: 2577457
    [Abstract] [Full Text] [Related]

  • 23. Treating hypertension and cardiovascular risk: are there trade-offs?
    Grimm RH.
    Am Heart J; 1990 Mar; 119(3 Pt 2):729-32; discussion 732. PubMed ID: 1968699
    [Abstract] [Full Text] [Related]

  • 24. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL.
    Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [Abstract] [Full Text] [Related]

  • 25. Effects of treatment with diuretics on serum lipoproteins.
    Weidmann P, Gerber A.
    J Cardiovasc Pharmacol; 1984 Sep; 6 Suppl 1():S260-8. PubMed ID: 6204152
    [Abstract] [Full Text] [Related]

  • 26. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M.
    Am J Cardiol; 1989 Jan 17; 63(4):2B-7B. PubMed ID: 2563187
    [Abstract] [Full Text] [Related]

  • 27. The effects of diuretics and adrenergic-blocking agents on plasma lipids.
    Rohlfing JJ, Brunzell JD.
    West J Med; 1986 Aug 17; 145(2):210-8. PubMed ID: 2876554
    [Abstract] [Full Text] [Related]

  • 28. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul 17; 27(7):313-9. PubMed ID: 2570758
    [Abstract] [Full Text] [Related]

  • 29. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN.
    Drugs; 1984 Jul 17; 28 Suppl 2():51-68. PubMed ID: 6151891
    [Abstract] [Full Text] [Related]

  • 30. Alpha blockers and vasodilating beta blockers--influence on factors involved in the pathogenesis of vascular disease in patients with hypertension.
    Louis WJ, Drummer OH, Howes LG.
    Clin Exp Hypertens A; 1989 Jul 17; 11(5-6):1075-83. PubMed ID: 2571433
    [Abstract] [Full Text] [Related]

  • 31. Goals of antihypertensive therapy.
    McVeigh GE, Flack J, Grimm R.
    Drugs; 1995 Feb 17; 49(2):161-75. PubMed ID: 7729325
    [Abstract] [Full Text] [Related]

  • 32. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W.
    Z Kardiol; 1992 Jun 17; 81(6):295-302. PubMed ID: 1353932
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG.
    Clin Ther; 1986 Jun 17; 8(5):490-509. PubMed ID: 2876774
    [Abstract] [Full Text] [Related]

  • 34. Antihypertensive therapy in diabetic patients.
    Weidmann P, Boehlen LM, de Courten M, Ferrari P.
    J Hum Hypertens; 1992 Dec 17; 6 Suppl 2():S23-36. PubMed ID: 1289510
    [Abstract] [Full Text] [Related]

  • 35. [Effect of diuretics on serum lipoproteins].
    Sönnichsen AC, Richter WO, Schwandt P.
    Fortschr Med; 1992 Nov 30; 110(33):625-8. PubMed ID: 1478604
    [Abstract] [Full Text] [Related]

  • 36. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    Torvik D, Madsbu HP.
    Am J Cardiol; 1987 May 29; 59(14):68G-72G. PubMed ID: 2884855
    [Abstract] [Full Text] [Related]

  • 37. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun 29; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 38. Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapy.
    Rosenthal J.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1763-6. PubMed ID: 2904747
    [Abstract] [Full Text] [Related]

  • 39. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR, Glassman HN, Estep CB, Maurath CJ, Jordan DC.
    Am Heart J; 1989 Apr 29; 117(4):842-7. PubMed ID: 2564723
    [Abstract] [Full Text] [Related]

  • 40. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ.
    Circulation; 1997 Apr 15; 95(8):2007-14. PubMed ID: 9133508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.